期刊文献+

冠心病患者氯吡格雷抵抗的研究进展 被引量:19

Clopidogrel Resistance in Patients with Coronary Heart Disease
下载PDF
导出
摘要 "氯吡格雷抵抗"是心血管领域近年来使用越来越多的一个术语,用来描述服用氯吡格雷后在血小板功能抑制方面未能达到预期作用的现象。研究表明,氯吡格雷抵抗可能与血栓事件的反复发生及亚急性支架内血栓的形成有重要关系。氯吡格雷抵抗可能受多方面因素的影响,包括外部因素和内部因素。迄今为止,其确切机制尚未完全阐明。现就目前有关氯吡格雷抵抗的研究证据作一综述。 Clopidogrel resistance is a widely used term that is not yet clearly defined. Up to now,it has been used to describe the failure of clopidogrel to achieve its anti-aggregatory effect ,or a clinical entity with potentially severe consequences such as recurrent myocardial infarction ,stroke or death. The mechanism of resistance is multifactorial. It can be due to extrinsic or intrinsic mechanisms. Presently ,the best laboratory procedure to screen for possible clopidogrel variability of response remains to be determined. This article discusses currently available evidence surrounding the variability in the anti-platelet response to clopidogrel.
出处 《心血管病学进展》 CAS 2008年第3期419-422,共4页 Advances in Cardiovascular Diseases
关键词 氯吡格雷 氯吡格雷抵抗 血小板聚集 clopidogrel clopidogrel resistance platelet aggregation
  • 相关文献

参考文献33

  • 1Tolleson TR,Newby LK,Harrington RA,et al. Frequency of stent thrombosis after acute coronary syndromes ( horn the SYMPHONY and 2nd SYMPHONY trials) [J]. Am J Cardio1,2003 ,92 :330-333.
  • 2Muller I, Besta F, Schulz C, et al. Prevalence of clopidogrel nonresponders among patients with stable angina pectoris scheduled for elective coronary stent placement [ J ]. Thromb Haemost ,2003,89:783-787.
  • 3Matetzky S,Shenkman B,Guetta V,et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombofic events in patients with acute myocardial infarction [ J]. Circulation ,2004,109:3171-3175.
  • 4Wiviott SD,Antman EM. Clopidogrel resistance:a new chapter in a fast-moving story[J]. Circulation, 2004,109 : 3064-3067.
  • 5Nguyen TA, Diodati JG, Pharand C,et al. Resistance to clopidogrel:a review of the evidence[ J] .J Am Coll Cardiol,2005,1945 (8) :1157-1164.
  • 6Lau WC ,Gurbel PA,Watkins PB,et al. Contribution of hepatic eytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance [ J]. Circulation ,2004,109 : 166-171.
  • 7Gurbel PA,Bliden KP,Hiatt BL,et al. Clopidogrel for coronary stenting response variability ,drug resistance,and the effect of pretreatment platelet reactivity [ J]. Circulation ,2003,107:2908-2913.
  • 8Wenaweser P, Dorffler Melly J, Imhoden K, et al. Stent thrombosis is associated with an impaired response to antiplatelet therapy [J]. J Am Coll Cardiol,2005, 745 ( 11 ) :1748-1752.
  • 9Schumann A,Wiesenburg A ,Bueha E,et al. Platelet Adhesion Assay ( PADA), a new quantitative test for assessment of platdet function and the apeufie drug monitoring of GP Ⅱ b / Ⅲ a and ADP receptor antagonists [ J ]. Hamostaseologie, 2004,24 (3) :211-216.
  • 10Lepantalo A,Virtanen KS,Heikkila J, et al. Limited early antiplatelet effect of 300mg elopidogrel in patients with aspirin therapy undergoing pereutaneous coronary interventions[J]. Eur Heart J,2004,25 (6) :476-483.

同被引文献111

引证文献19

二级引证文献109

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部